Uncategorized

Acelyrin founder Shao-Lee Lin emerges at Cue, as it becomes latest to license from China

Published

3 hours ago

on

Cue Biopharma announced a reboot Thursday afternoon, bringing in notable biotech executive Shao-Lee Lin as well as a new allergy asset developed in Taiwan and mainland China.

The Boston-based biotech has focused on developing T …

Related Topics:

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version